Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 24 March 1989:
Vol. 243. no. 4898, pp. 1600 - 1603
DOI: 10.1126/science.2648572
Prev | Table of Contents | Next

Articles

Science, Vol 243, Issue 4898, 1600-1603
Copyright © 1989 by American Association for the Advancement of Science

articles

Activation of the cellular proto-oncogene product p21Ras by addition of a myristylation signal

JE Buss, PA Solski, JP Schaeffer, MJ MacDonald, and CJ Der

La Jolla Cancer Research Foundation, CA 92037.

The 21-kD proteins encoded by ras oncogenes (p21Ras) are modified covalently by a palmitate attached to a cysteine residue near the carboxyl terminus. Changing cysteine at position 186 to serine in oncogenic forms produces a nonpalmitylated protein that fails to associate with membranes and does not transform NIH 3T3 cells. Nonpalmitylated p21Ras derivatives were constructed that contained myristic acid at their amino termini to determine if a different form of lipid modification could restore either membrane association or transforming activity. An activated p21Ras, altered in this way, exhibited both efficient membrane association and full transforming activity. Surprisingly, myristylated forms of normal cellular Ras were also transforming. This demonstrates that Ras must bind to membranes in order to transmit a signal for transformation, but that either myristate or palmitate can perform this role. However, the normal function of cellular Ras is diverted to transformation by myristate and therefore must be regulated ordinarily by some unique property of palmitate that myristate does not mimic. Myristylation thus represents a novel mechanism by which Ras can become transforming.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Farnesyltransferase Inhibitors: An Overview of the Results of Preclinical and Clinical Investigations.
T. B. Brunner, S. M. Hahn, A. K. Gupta, R. J. Muschel, W. G. McKenna, and E. J. Bernhard (2003)
Cancer Res. 63, 5656-5668
   Abstract »    Full Text »    PDF »
Transformation of Rodent Fibroblasts by the Jaagsiekte Sheep Retrovirus Envelope Is Receptor Independent and Does Not Require the Surface Domain.
Y.-H. J. Chow, A. Alberti, M. Mura, C. Pretto, P. Murcia, L. M. Albritton, and M. Palmarini (2003)
J. Virol. 77, 6341-6350
   Abstract »    Full Text »    PDF »
Critical Role of the Pleckstrin Homology Domain in Dbs Signaling and Growth Regulation.
E. J. Fuentes, A. E. Karnoub, M. A. Booden, C. J. Der, and S. L. Campbell (2003)
J. Biol. Chem. 278, 21188-21196
   Abstract »    Full Text »    PDF »
Targeting Ras signaling through inhibition of carboxyl methylation: An unexpected property of methotrexate.
A. M. Winter-Vann, B. A. Kamen, M. O. Bergo, S. G. Young, S. Melnyk, S. J. James, and P. J. Casey (2003)
PNAS 100, 6529-6534
   Abstract »    Full Text »    PDF »
Critical but Distinct Roles for the Pleckstrin Homology and Cysteine-Rich Domains as Positive Modulators of Vav2 Signaling and Transformation.
M. A. Booden, S. L. Campbell, and C. J. Der (2002)
Mol. Cell. Biol. 22, 2487-2497
   Abstract »    Full Text »    PDF »
Role of a Mitogen-activated Protein Kinase Pathway in the Induction of Phase II Detoxifying Enzymes by Chemicals.
R. Yu, W. Lei, S. Mandlekar, M. J. Weber, C. J. Der, J. Wu, and A.-N. T. Kong (1999)
J. Biol. Chem. 274, 27545-27552
   Abstract »    Full Text »    PDF »
Overexpression of the Receptor for Hyaluronan-Mediated Motility (RHAMM) Characterizes the Malignant Clone in Multiple Myeloma: Identification of Three Distinct RHAMM Variants.
M. Crainie, A. R. Belch, M. J. Mant, and L. M. Pilarski (1999)
Blood 93, 1684-1696
   Abstract »    Full Text »    PDF »
A Non-farnesylated Ha-Ras Protein Can Be Palmitoylated and Trigger Potent Differentiation and Transformation.
M. A. Booden, T. L. Baker, P. A. Solski, C. J. Der, S. G. Punke, and J. E. Buss (1999)
J. Biol. Chem. 274, 1423-1431
   Abstract »    Full Text »    PDF »
B-cell-specific Coactivator OCA-B: Biochemical Aspects, Role in B-Cell Development and Beyond.
Y. LUO and R.G. ROEDER (1999)
Cold Spring Harb Symp Quant Biol 64, 119-132
   Abstract »    PDF »
Genetic Analysis of the Rat Leukemia Virus: Influence of Viral Sequences in Transduction of the c-ras Proto-Oncogene and Expression of Its Transforming Activity.
S.-Y. Lee, T. M. Howard, and S. Rasheed (1998)
J. Virol. 72, 9906-9917
   Abstract »    Full Text »    PDF »
A Raf-independent Epidermal Growth Factor Receptor Autocrine Loop Is Necessary for Ras Transformation of Rat Intestinal Epithelial Cells.
L. M. Gangarosa, N. Sizemore, R. Graves-Deal, S. M. Oldham, C. J. Der, and R. J. Coffey (1997)
J. Biol. Chem. 272, 18926-18931
   Abstract »    Full Text »    PDF »
Ras CAAX Peptidomimetic FTI-277 Selectively Blocks Oncogenic Ras Signaling by Inducing Cytoplasmic Accumulation of Inactive Ras-Raf Complexes.
E. C. Lerner, Y. Qian, M. A. Blaskovich, R. D. Fossum, A. Vogt, J. Sun, A. D. Cox, C. J. Der, A. D. Hamilton, and S.īd M. Sebti (1995)
J. Biol. Chem. 270, 26802-26806
   Abstract »    Full Text »    PDF »
Expression Cloning of lfc, a Novel Oncogene with Structural Similarities to Guanine Nucleotide Exchange Factors and to the Regulatory Region of Protein Kinase C.
I. Whitehead, H. Kirk, C. Tognon, G. Trigo-Gonzalez, and R. Kay (1995)
J. Biol. Chem. 270, 18388-18395
   Abstract »    Full Text »    PDF »
Protein lipidation in cell signaling.
P. Casey (1995)
Science 268, 221-225
   Abstract »    PDF »
The effect of posttranslational modifications on the interaction of Ras2 with adenylyl cyclase.
Y Kuroda, N Suzuki, and T Kataoka (1993)
Science 259, 683-686
   Abstract »    PDF »
Mutation of Ha-Ras C Terminus Changes Effector Pathway Utilization.
M. A. Booden, D. S. Sakaguchi, and J. E. Buss (2000)
J. Biol. Chem. 275, 23559-23568
   Abstract »    Full Text »    PDF »
S-Nitrosocysteine Increases Palmitate Turnover on Ha-Ras in NIH 3T3 Cells.
T. L. Baker, M. A. Booden, and J. E. Buss (2000)
J. Biol. Chem. 275, 22037-22047
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)